IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery
World Pharma Today | January 02, 2017
IBM Watson Health and Pfizer Inc announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer.